How would you approach immunosuppression for patients with severe aplastic anemia who are not transplant or ATG candidates?  

Such as patients who are frail, elderly, renally impaired?

Would you consider sirolimus over cyclosporine or tacrolimus for safer nephrotoxicity profile?



Answer from: at Academic Institution
Comments
at Kaiser Permanente, Los Angeles Med Center
Thank you, Dr. @Joseph H. Antin! Very helpful.
Sign in or Register to read more